SKU: C-1106-5mg
NVP-CGM-097 (CGM-097) Chemical Formula: C38H47ClN4O4 Solid Powder
  • Catalog#: C-1106
  • Targets: MDM2
  • Synonym: CGM097; CGM-097; CGM 097; NVPCGM097; NVPCGM 097; NVPCGM-097
  • Chemical Name/IUPAC:(S)-1-(4-chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4S)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one
  • SMILES Code: O=C1N(C2=CC=C(N(C)C[C@H]3CC[C@H](N4CC(N(C)CC4)=O)CC3)C=C2)[C@@H](C5=CC=C(Cl)C=C5)C6=C(C=C(OC)C(OC(C)C)=C6)C1
    Technical Data
  • Product Name: NVP-CGM-097 (CGM-097)
  • Chemical Formula: C38H47ClN4O4
  • Molecular Weight: 659.26
  • CAS#: 1313363-54-0
  • Appearance: Solid powder
  • Purity: > 99% by HPLC
  • Solubility: Soluble in DMSO
  • Storage: Room temperature for months, or -20ºC for 3 years
    NVP-CGM-097 (CGM-097) is an orally bioavailable HDM2 (human homolog of double minute 2) antagonist with potential antineoplastic activity. Upon oral administration, p53/HDM2 interaction inhibitor CGM097 inhibits the binding of the HDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this HDM2-p53 interaction, the proteosome-mediated enzymatic degradation of p53 is inhibited, which may result in the restoration of p53 signaling and, thus, the p53-mediated induction of tumor cell apoptosis. HDM2, a zinc finger nuclear phosphoprotein, is a negative regulator of the p53 pathway, often overexpressed in cancer cells and has been implicated in cancer cell proliferation and survival.